-
Thematic Analysis
Synthetic Biology – Thematic Intelligence
Synthetic Biology Thematic Report Overview Synthetic biology is commonly abbreviated to synbio. It involves the manipulation of genetic material to enhance specific characteristics or, conversely, stifle them. The ability to perform this manipulation quickly, precisely, and at a low cost has the potential to impact numerous sectors. From developing environmentally friendly luxury materials to novel cancer therapeutics and even the use of DNA as a new form of data storage, the forthcoming field of synbio unlocks several new realms of...
-
Product Insights
Acquired Gene or Chromosome Alterations Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies
Acquired Gene or Chromosome Alterations Pipeline Market Report Overview Acquired Gene or Chromosome Alterations are reagents employed for genetic testing to detect cancer-causing or related alterations. The Acquired Gene or Chromosome Alterations pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Product Insights
NewMGI Tech Co Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our MGI Tech Co Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. MGI Tech Co Ltd (MGI Tech), a subsidiary of BGI Genomics Co Ltd, is a genomics company. It focuses on research, development, manufacturing and sales of DNA sequencing instruments and reagents. The company offers sequencers for whole genome sequencing, deep exome sequencing, transcriptome sequencing, targeted DNA, epigenetics and clinical applications. It also provides automated sample preparation systems and...
-
Sector Analysis
Communications Service Provider M&A in AME: Key Trends and Insights
The CSPs (Communication Service Providers) are leveraging M&A to enhance their internal and external capabilities, products, and services. Such capabilities can extend to their enterprise services, as telcos invest in cybersecurity, system integration/professional B2B ICT services, and data centers (DCs). Such M&A help CSPs manage, deliver, and develop new technological capabilities and services. The CSP M&As in AME has covered the cybersecurity, fintech, and healthtech segments, as these services can be bundled with existing services, which can provide a strong...
-
Product Insights
COVID 19 Nucleic Acid Amplification Tests (NAATs) – Medical Devices Pipeline Assessment, 2020
COVID 19 NAAT tests are highly sensitive tests and can easily detect the low density infections. The types of NAAT tests are Polymerase chain reaction (PCR) – including nested (n), quantitative (q) or real-time reverse transcription (RT) PCR), quantitative nucleic acid sequence-based amplification (QT-NASBA) and loop mediated isothermal amplification (LAMP). GlobalData's Medical Devices sector report, “COVID 19 Nucleic Acid Amplification Tests (NAATs) - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the COVID 19 Nucleic Acid Amplification Tests (NAATs)...
-
Product Insights
Retrovirus Tests – Medical Devices Pipeline Assessment, 2020
Retrovirus Tests are the diagnostic tests used to detect the antigen/antibody of HIV1, HIV 2 (human immunodeficiency virus) and HTLV I, HTLV II (human T-cell lymphotropic virus) viruses. GlobalData's Medical Devices sector report, “Retrovirus Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Retrovirus Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Retrovirus Tests Pipeline Assessment report provides key information and data...
-
Product Insights
Colorectal Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Colorectal Cancer Diagnostic Tests are used for detection of CRC based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient’s sample. GlobalData's Medical Devices sector report, “Colorectal Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Colorectal Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Colorectal Cancer Diagnostic Tests Pipeline Assessment report provides key information and...
-
Product Insights
Lung Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Lung Cancer Diagnostic Tests include assays of mostly antibodies released in response to a lung cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Lung Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Lung Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Lung Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...
-
Sector Analysis
United Kingdom In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others.
GlobalData’s “United Kingdom In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United Kingdom In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United Kingdom In Vitro Diagnostics Market report provides key information and data on: • Annualized market...